Ole Bjarne Christiansen

Aalborg University Hospital — Denmark

Immunology and Microbiology · Life Sciences

47h-index9.7kcitations247works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Reproductive System and Pregnancy(139), Ectopic Pregnancy Diagnosis and Management(76), Pregnancy and preeclampsia studies(51), Prenatal Screening and Diagnostics(33), Pregnancy and Medication Impact(29)

Publications246 total

Intravenous immunoglobulin and prednisolone to women with unexplained recurrent pregnancy loss after assisted reproductive technology treatment: a randomised, double-blind, placebo-controlled trial
BMJ Open·2025· 2 citedOpen Access
Intravenous immunoglobulin versus placebo in recurrent pregnancy loss: A systematic review and meta-analysis of randomized trials
Journal of Reproductive Immunology·2025· 2 citedOpen Access
INTRAVENOUS IMMUNOGLOBULIN AND PREDNISOLONE TO WOMEN WITH UNEXPLAINED RECURRENT PREGNANCY LOSS UNDERGOING ASSISTED REPRODUCTIVE TECHNOLOGY TREATMENT: A RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED TRIAL
Journal of Reproductive Immunology·2025
Paternal <scp>HLA</scp>‐Derived Epitopes and Live Birth in Secondary Recurrent Pregnancy Loss: New Insights From a Clinical Trial
HLA·2024· 1 cited
Paternal HLA-Derived Epitopes and Live Birth in Secondary Recurrent Pregnancy Loss: New Insights From a Clinical Trial
Utrecht University Repository (Utrecht University)·2024Open Access
SIOG2024-2-P-034 Objective physical function of older prostate cancer survivors and matched controls, a descriptive comparison
Journal of Geriatric Oncology·2024
O-032 Intravenous immunoglobulin and prednisolone to women with unexplained recurrent pregnancy loss undergoing assisted reproductive technology treatment: a randomized, double-blinded, placebo-controlled trial
Human Reproduction·2024
P-386 The effect of intravenous immunoglobulin versus placebo in patients with recurrent pregnancy loss: a systematic review and meta-analysis of randomized trials
Human Reproduction·2024Open Access
Prediction of large‐for‐gestational‐age at birth using fetal biometry in type 1 and type 2 diabetes: A retrospective cohort study
International Journal of Gynecology & Obstetrics·2024· 3 citedOpen Access
Seminal Oxidative Stress and Sperm DNA Fragmentation in Men from Couples with Infertility or Unexplained Recurrent Pregnancy Loss
Journal of Clinical Medicine·2024· 5 citedOpen Access
Strong anti-fetal HLA antibodies are associated with recurrent pregnancy loss with a diagnosis of chronic histiocytic intervillositis
Journal of Reproductive Immunology·2023Open Access
11:50-12:00 A firstborn boy and maternal HLA class II polymorphism negatively affect pregnancy prognosis in recurrent pregnancy loss
Journal of Reproductive Immunology·2023
P-488 Pregnancy loss rate in recurrent pregnancy loss patients according to gestational week: life tables for clinical guidance of patients during supportive care before week 24
Human Reproduction·2023Open Access
P-530 Which evacuation method for missed abortion is preferred by women with recurrent pregnancy loss?
Human Reproduction·2023Open Access
A core outcome set for trials in miscarriage management and prevention: An international consensus development study
BJOG An International Journal of Obstetrics & Gynaecology·2023· 14 citedOpen Access
Anti-Müllerian hormone and live birth in unexplained recurrent pregnancy loss
Reproductive BioMedicine Online·2023· 3 citedOpen Access
A combination of the HLA-DRB1*03 phenotype and low plasma mannose-binding lectin predisposes to autoantibody formation in women with recurrent pregnancy loss
Frontiers in Immunology·2023· 6 citedOpen Access
Maternal carriage of H-Y restricting HLA class II alleles is a negative prognostic factor for women with recurrent pregnancy loss after birth of a boy
Journal of Reproductive Immunology·2023· 1 citedOpen Access
ESHRE guideline: recurrent pregnancy loss: an update in 2022
Human Reproduction Open·2022· 342 citedOpen Access
Intravenous immunoglobulin and prednisolone to women with unexplained recurrent pregnancy loss after assisted reproductive technology treatment: a protocol for a randomised, double-blind, placebo-controlled trial
BMJ Open·2022· 7 citedOpen Access
page 1 of 13Next →

Frequent Co-authors

Henriette Svarre Nielsen(17), Astrid Marie Kolte(14), Siobhan Quenby(8), Mariëtte Goddijn(7), David A. Peters(7), Niels Uldbjerg(7), Anne Sørensen(7), Mary D. Stephenson(6), Anne‐Marie Nybo Andersen(6), Rudi Steffensen(5), Marianne Sinding(5), Jens Brøndum Frøkjær(5), Ioannis Gallos(4), Rima Dhillon‐Smith(4), Jan J. Brosens(4), Jane Brewin(4), Lesley Regan(4), M. Al‐Memar(4), T. Bourne(4), Adam Devall(4)